Covered recipient · General Payments record
CARLY RUBIN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,287.71
- Reported across 102 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.72 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $190.58 | 13 |
| Acerta Pharma LLC | $175.00 | 4 |
| Novo Nordisk AS | $51.52 | 2 |
| Amgen Inc. | $49.02 | 2 |
| Exact Sciences Corporation | $44.46 | 2 |
| Merck Sharp & Dohme Corporation | $38.28 | 2 |
| PFIZER INC. | $26.53 | 1 |
| Indivior Inc. | $23.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.76 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120923 | CMS |
| ABBVIE INC. | $4.46 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120925 | CMS |
| ABBVIE INC. | $18.09 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120927 | CMS |
| ABBVIE INC. | $14.96 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120929 | CMS |
| ABBVIE INC. | $11.74 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120931 | CMS |
| ABBVIE INC. | $15.72 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120933 | CMS |
| ABBVIE INC. | $24.67 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120935 | CMS |
| ABBVIE INC. | $34.59 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120937 | CMS |
| ABBVIE INC. | $20.28 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120939 | CMS |
| ABBVIE INC. | $12.99 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120941 | CMS |
| ABBVIE INC. | $10.62 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120943 | CMS |
| ABBVIE INC. | $1.15 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120945 | CMS |
| ABBVIE INC. | $2.55 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120947 | CMS |
| Amgen Inc. | $25.27 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117671053 | CMS |
| Amgen Inc. | $23.75 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117671055 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.56 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104434009 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104284971 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.57 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105863446 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.87 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104448681 | CMS |
| Exact Sciences Corporation | $20.21 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114863350 | CMS |
| Exact Sciences Corporation | $24.25 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114863358 | CMS |
| Indivior Inc. | $23.33 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569632 | CMS |
| Merck Sharp & Dohme LLC | $16.55 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141815857 | CMS |
| Merck Sharp & Dohme LLC | $21.73 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141907946 | CMS |
| Novo Nordisk Inc | $23.17 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100611300 | CMS |
| Novo Nordisk Inc | $28.35 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100596171 | CMS |
| PFIZER INC. | $26.53 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130995901 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.